ABOS Acumen Pharmaceuticals Inc

Price (delayed)

$3.23

Market cap

$194.06M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.06

Enterprise value

$177.48M

Highlights
The company's quick ratio has surged by 87% YoY and by 59% QoQ
The company's equity rose by 46% YoY
Acumen Pharmaceuticals's net income has decreased by 24% YoY and by 7% from the previous quarter

Key stats

What are the main financial stats of ABOS
Market
Shares outstanding
60.08M
Market cap
$194.06M
Enterprise value
$177.48M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.74
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$54.36M
EBITDA
-$54.18M
Free cash flow
-$50.78M
Per share
EPS
-$1.06
Free cash flow per share
-$0.85
Book value per share
$4.36
Revenue per share
$0
TBVPS
$5.03
Balance sheet
Total assets
$300.97M
Total liabilities
$38.93M
Debt
$30.58M
Equity
$262.03M
Working capital
$247.36M
Liquidity
Debt to equity
0.12
Current ratio
30.2
Quick ratio
29.83
Net debt/EBITDA
0.31
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-20.8%
Return on equity
-22.9%
Return on invested capital
-26.7%
Return on capital employed
-18.6%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ABOS stock price

How has the Acumen Pharmaceuticals stock price performed over time
Intraday
12.54%
1 week
11.38%
1 month
39.83%
1 year
-56.35%
YTD
-15.89%
QTD
33.47%

Financial performance

How have Acumen Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$65.78M
Net income
-$55.94M
Gross margin
N/A
Net margin
N/A
Acumen Pharmaceuticals's operating income has decreased by 34% YoY and by 8% QoQ
Acumen Pharmaceuticals's net income has decreased by 24% YoY and by 7% from the previous quarter

Growth

What is Acumen Pharmaceuticals's growth rate over time

Valuation

What is Acumen Pharmaceuticals stock price valuation
P/E
N/A
P/B
0.74
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Acumen Pharmaceuticals's EPS has increased by 4.5% YoY
The company's equity rose by 46% YoY
The P/B is 18% less than the last 4 quarters average of 0.9

Efficiency

How efficient is Acumen Pharmaceuticals business performance
ABOS's ROIC has soared by 56% YoY and by 18% from the previous quarter
ABOS's ROA is up by 8% year-on-year and by 4.6% since the previous quarter
ABOS's return on equity is up by 2.1% since the previous quarter and by 2.1% year-on-year

Dividends

What is ABOS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ABOS.

Financial health

How did Acumen Pharmaceuticals financials performed over time
The company's quick ratio has surged by 87% YoY and by 59% QoQ
ABOS's current ratio has soared by 84% year-on-year and by 59% since the previous quarter
The company's debt is 88% lower than its equity
The company's equity rose by 46% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.